HKG:1177 Sino Biopharm
1 min read

HKG:1177 Sino Biopharm

HKG:1177 Sino Biopharm operates in the field of Medicine. The Group’s business works in a fully integrated chain which spans from R&D to manufacture and sales of pharmaceutical products, covering a vast array of biopharmaceutical, chemical and modernized Chinese medicines. Interim result 2022 are favorable for dividends (+200%) yet EPS fell 77%

HKG:1177 Sino Biopharm

Last update: 14-Feb-24

Quick overview:

    • Yield: 4.12%

(See here Top 10 highest yield)

    • Lot: 1000
    • Price/Earnings ratio : 29.10 (Ideal <20 )
    • Earnings per share : 0.100 (Ideal >0.001)
    • Price as per 14-Feb-24 : HK$2.91
    • Ex-Dividend Date coming up:  N/A

See here all upcoming Ex-Dividend dates

Log in, to see this page

Get access to expert data in 5 minutes

Instantly get your spreadsheet of the 25 Highest yield Hong Kong Dividend Growth stocks

Yes for FREE, no spam.